17.50

1.35% -0.24

Odyssey Therapeutics Inc (ODTX)

Overview News Price History Discussions Forecast

Odyssey Therapeutics Inc stock is traded at $17.50, with a volume of 323.58K. It is down -1.35% in the last 24 hours and up +0.00% over the past month. Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Previous Close:

$17.74

Open:

$17.56

24h Volume:

323.58K

Relative Volume:

6.03

Market Cap:

$825.55M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-0.68%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$16.50

$18.43

1-Week Range:

$16.50

$18.43

52-Week Range:

$16.41

$18.43

Odyssey Therapeutics Inc Stock (ODTX) Company Profile

Name

Odyssey Therapeutics Inc

Sector

Healthcare (1108)

Industry

Biotechnology (618)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

ODTX's Discussions on Twitter

Compare ODTX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ODTX Odyssey Therapeutics Inc	17.50	836.87M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	434.52	110.03B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	638.88	67.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	806.46	50.76B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	297.45	40.12B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	151.56	32.68B	742.00K	-1.37B	-1.07B	-7.0731

Odyssey Therapeutics Inc Stock (ODTX) Latest News

May 22, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

May 22, 2026

May 21, 2026

Odyssey Therapeutics hits $900M valuation in Nasdaq debut, stock climbs 13% before diving lower - MSN

May 21, 2026

May 20, 2026

IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace

May 20, 2026

May 19, 2026

Odyssey Therapeutics (ODTX) Stock Analysis Report | Financials & Insights - Benzinga

May 19, 2026

May 18, 2026

Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake - TradingView

May 18, 2026

SR One funds disclose 8% Odyssey Therapeutics (ODTX) stake after IPO - Stock Titan

May 18, 2026

TPG funds take 7.8% Odyssey Therapeutics (ODTX) stake via $25M share purchase - Stock Titan

May 18, 2026

Odyssey Therapeutics (ODTX) 10K Form and Latest SEC Filings 2026 - MarketBeat

May 18, 2026

May 15, 2026

Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026 - MarketBeat

May 15, 2026

Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake - TradingView

May 15, 2026

Jeito II S.L.P. Discloses Investment in Odyssey Therapeutics with 7.8% Stake - TradingView

May 15, 2026

What is the current Price Target and Forecast for Odyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research

May 15, 2026

Odyssey Therapeutics Prices $304 Million Upsized IPO and Concurrent Private Placement - Global Legal Chronicle

May 14, 2026

Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - MarketBeat

May 14, 2026

ODTX Price History for Odyssey Therapeutics Stock - Barchart.com

May 14, 2026